BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:31 PM
 | 
Jun 01, 2009
 |  BC Extra  |  Company News

FDA accepts Stedesa NDA

Sepracor Inc. (NASDAQ:SEPR) said FDA accepted for review an NDA for Stedesa eslicarbazepine as adjunctive therapy...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >